These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder. Boellner SW; Pennick M; Fiske K; Lyne A; Shojaei A Pharmacotherapy; 2007 Sep; 27(9):1253-62. PubMed ID: 17723079 [TBL] [Abstract][Full Text] [Related]
24. Sudden death in children treated with a tricyclic antidepressant. Med Lett Drugs Ther; 1990 Jun; 32(819):53. PubMed ID: 2342435 [No Abstract] [Full Text] [Related]
25. Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder. Ibrahim el SR Hum Psychopharmacol; 2002 Jul; 17(5):225-31. PubMed ID: 12404679 [TBL] [Abstract][Full Text] [Related]
27. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Klassen AF; Miller A; Fine S Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087 [TBL] [Abstract][Full Text] [Related]
28. Bipolar disorder and attention-deficit/hyperactivity disorder in children and adolescents. Giedd JN J Clin Psychiatry; 2000; 61 Suppl 9():31-4. PubMed ID: 10826658 [TBL] [Abstract][Full Text] [Related]
30. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment. Gadow KD; Nolan E; Sprafkin J; Sverd J J Dev Behav Pediatr; 1995 Jun; 16(3):167-76. PubMed ID: 7560119 [TBL] [Abstract][Full Text] [Related]
31. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. Wilens TE J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375 [TBL] [Abstract][Full Text] [Related]
32. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents. Biederman J; Pliszka SR J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848 [TBL] [Abstract][Full Text] [Related]
33. Resolved: cardiac arrhythmias make desipramine an unacceptable choice in children. Werry JS; Biederman J; Thisted R; Greenhill L; Ryan N J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1239-45; discussion 1245-8. PubMed ID: 7559320 [No Abstract] [Full Text] [Related]
35. Attention-deficit hyperactivity disorder; AIDS in children and adolescents. Alger I Hosp Community Psychiatry; 1989 Dec; 40(12):1222-3. PubMed ID: 2480324 [No Abstract] [Full Text] [Related]
36. [The hyperkinetic syndrome and its relation to the syndrome of attention deficit disorder]. Lerman P Harefuah; 1986 Mar; 110(6):298-300. PubMed ID: 3525349 [No Abstract] [Full Text] [Related]
39. The drug-placebo response curve: a new method for assessing drug effects in clinical trials. Faraone SV; Biederman J; Spencer TJ; Wilens TE J Clin Psychopharmacol; 2000 Dec; 20(6):673-9. PubMed ID: 11106140 [TBL] [Abstract][Full Text] [Related]
40. Sudden death in children receiving Norpramin: a review of three reported cases and commentary. Riddle MA; Nelson JC; Kleinman CS; Rasmusson A; Leckman JF; King RA; Cohen DJ J Am Acad Child Adolesc Psychiatry; 1991 Jan; 30(1):104-8. PubMed ID: 2005044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]